SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Viyash Scientific informs about board meeting

12 May 2026 Evaluate
Viyash Scientific has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, May 19, 2026, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026; recommend dividend, if any, on the equity shares of the Company for the year ended March 31, 2026.

The above information is a part of company’s filings submitted to BSE.

Viyash Scientific Share Price

251.90 -5.40 (-2.10%)
10-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.10
Dr. Reddys Lab 1271.75
Cipla 1376.25
Zydus Lifesciences 1097.90
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×